A medicine for treating dermatosis

A technology for skin diseases and drugs, applied in the field of drugs for treating skin diseases, can solve problems such as toxic side effects, irritation of human skin, and inaccurate curative effects of skin disease drugs, and achieve definite curative effect, low price, and promote skin cell protein synthesis Effect

Inactive Publication Date: 2006-12-27
李中变
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] However, so far, the efficacy of various drugs for the treatment of skin diseases caused by fungal infections is not very accurate.
Although some drugs have definite curative effects, they have toxic side effects and stimulate human skin.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] The formula that present embodiment adopts is as follows:

[0024] Hassinide 1;

[0025] Prednisone acetate 6;

[0026] Diphenhydramine hydrochloride 0.3;

[0027] Chloramphenicol 200;

[0028] Griseofulvin 80;

[0029] Sulfur 200;

[0030] Dexamethasone 0.75.

[0031] Production process: pulverize the above-mentioned raw materials, add water after mixing, and prepare into a paste.

[0032] Usage and dosage: first wash the part with light salt water or light vinegar water, after drying, smear the affected part with the medicine provided by the present invention, 2-3 times a day, and once at night before going to bed. Continue to use for a week after the symptoms disappear to consolidate the curative effect.

[0033] Application description:

[0034] Use the medicine provided by the present invention to treat 60 people with skin diseases, including 20 people with psoriasis, 15 people with flaky eczema, 21 people with tinea corporis, and 4 others. Use medicine pr...

Embodiment 2

[0037] The formula that present embodiment adopts is as follows:

[0038] Hascinide 0.2;

[0039] Prednisone acetate 10;

[0040] Diphenhydramine hydrochloride 0.1;

[0041] Chloramphenicol 160;

[0042] Griseofulvin 30;

[0043] Sulfur 260;

[0044] Dexamethasone 0.5.

[0045] Production process: pulverize the above-mentioned raw materials, add water after mixing, and prepare into a paste.

[0046] Usage and dosage: first wash the part with light salt water or light vinegar water, after drying, smear the affected part with the medicine provided by the present invention, 2-3 times a day, and once at night before going to bed. Continue to use for a week after the symptoms disappear to consolidate the curative effect.

[0047] Application description:

[0048] Use the medicine provided by the present invention to treat 62 people with skin diseases, including 20 people with psoriasis, 15 people with flaky eczema, 22 people with tinea corporis, and 5 others. Use medicine ...

Embodiment 3

[0051] The formula that present embodiment adopts is as follows:

[0052] Hascinide 1.6;

[0053] prednisone acetate 2;

[0054] Diphenhydramine hydrochloride 0.6;

[0055] Chloramphenicol 80;

[0056] Griseofulvin 120;

[0057] Sulfur 100;

[0058] Dexamethasone 1.0.

[0059] Production process: pulverize the raw material drug in the stated amount, add alcohol after mixing, make a paste, add 10 parts of sodium benzoate

[0060] Usage and dosage: first wash the part with light salt water or light vinegar water, after drying, smear the affected part with the medicine provided by the present invention, 2-3 times a day, and once at night before going to bed. Continue to use for a week after the symptoms disappear to consolidate the curative effect.

[0061] Application description:

[0062] Use the medicine provided by the present invention to treat 61 people with skin diseases, including 20 people with psoriasis, 15 people with flaky eczema, 22 people with tinea corporis...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicament for treating skin diseases, wherein the effective constituents comprise the following raw materials (by weight ratio): Halcinonide 0.2-1.6, prednisone acetate 2-10, diphenhydramine hydrochloride 0.1-0.6, aquamycetin 80-160, spirofulvin 30-120, sulfur 100-260 and decacortin 0.5-1.0. The invention also provides the process for preparing the pharmaceutical composition.

Description

technical field [0001] The invention relates to a medicine, in particular to a medicine for treating skin diseases. Background technique [0002] Diseases caused by fungi are collectively referred to as "fungal diseases". Among them, dermatophytosis has the highest incidence rate and can occur in various parts of the body, such as perineum, hands, and feet. Fungi like warm and humid, and the most suitable temperature for shallow fungi is 22°C to 28°C: too dry is not conducive to the growth of fungi. Therefore, the incidence rate is high in summer, especially in southern my country. In addition, the local skin condition is also an important factor in determining whether ringworm occurs. For example, people who often wear rubber shoes or leather shoes, due to poor air permeability, the humidity and temperature of the feet increase. In this case, fungi are very easy to grow and ringworm occurs. [0003] But, so far, the curative effect of the medicine of various treatment be...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/534A61K9/06A61P17/00A61P31/10A61K31/58A61K31/573A61K31/352A61K31/165A61K31/138A61K31/125A61K33/04
Inventor 李中变
Owner 李中变
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap